N. BIBER Et Al. , "Cysteinyl-leukotriene receptor antagonist montelukast decreases blood-brain barrier permeability but does not prevent oedema formation in traumatic brain injury," BRAIN INJURY , vol.23, no.6, pp.577-584, 2009
BIBER, N. Et Al. 2009. Cysteinyl-leukotriene receptor antagonist montelukast decreases blood-brain barrier permeability but does not prevent oedema formation in traumatic brain injury. BRAIN INJURY , vol.23, no.6 , 577-584.
BIBER, N., Toklu, H. Z., Solakoglu, S., Gultomruk, M., HAKAN, T., BERKMAN, Z., ... Dulger, F. G.(2009). Cysteinyl-leukotriene receptor antagonist montelukast decreases blood-brain barrier permeability but does not prevent oedema formation in traumatic brain injury. BRAIN INJURY , vol.23, no.6, 577-584.
BIBER, Necat Et Al. "Cysteinyl-leukotriene receptor antagonist montelukast decreases blood-brain barrier permeability but does not prevent oedema formation in traumatic brain injury," BRAIN INJURY , vol.23, no.6, 577-584, 2009
BIBER, Necat Et Al. "Cysteinyl-leukotriene receptor antagonist montelukast decreases blood-brain barrier permeability but does not prevent oedema formation in traumatic brain injury." BRAIN INJURY , vol.23, no.6, pp.577-584, 2009
BIBER, N. Et Al. (2009) . "Cysteinyl-leukotriene receptor antagonist montelukast decreases blood-brain barrier permeability but does not prevent oedema formation in traumatic brain injury." BRAIN INJURY , vol.23, no.6, pp.577-584.
@article{article, author={Necat BIBER Et Al. }, title={Cysteinyl-leukotriene receptor antagonist montelukast decreases blood-brain barrier permeability but does not prevent oedema formation in traumatic brain injury}, journal={BRAIN INJURY}, year=2009, pages={577-584} }